Home | Welcome to Contract Pharma   
Last Updated Wednesday, June 19 2013
Print

Collaborations & Alliances

Related Searches:

Filter by:

September 6, 2012
Abbott’s RealTime CMV assay to monitor patients   Read More »
September 6, 2012
Expands portfolio of reagents for protein research   Read More »
September 4, 2012
UMK-121 to begin Phase I for ESLD   Read More »
September 4, 2012
Expands discovery service offerings   Read More »
September 4, 2012
To develop and manufacture self-injection technology   Read More »
August 21, 2012
To develop and commercialize Ophthalmic therapies   Read More »
August 21, 2012
Ipsen gains rights in key territories, Inspiration to handle worldwide development   Read More »
August 16, 2012
Aims to identify MS biomarkers for diagnostics   Read More »
August 16, 2012
To develop PI3K delta inhibitor   Read More »
August 15, 2012
Regulus gets $28 million upfront for lead cardiovascular/metabolic program   Read More »
August 14, 2012
Produces Phase I material   Read More »
August 13, 2012
Spans drug discovery through clinical manufacture   Read More »
August 13, 2012
Restructures minimum royalty obligation   Read More »
August 9, 2012
Will use profiling technology to streamline drug development   Read More »
August 7, 2012
Will increase global reach and accelerate product development   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On